Pictet & Cie (Europe) Sa Biogen Inc. Transaction History

Pictet & Cie (Europe) Sa

$4.19 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$212.02 - $267.71 $34,135 - $43,101	161 Added 6.72%	2,557 $551,000
Q3 2023 Nov 02, 2023	SELL	$253.3 - $285.89 $230,503 - $260,159	-910 Reduced 27.53%	2,396 $615,000
Q2 2023 Aug 08, 2023	SELL	$275.25 - $318.06 $79,822 - $92,237	-290 Reduced 8.06%	3,306 $941,000
Q1 2023 May 01, 2023	SELL	$256.56 - $292.34 $67,731 - $77,177	-264 Reduced 6.84%	3,596 $999,000
Q4 2022 Feb 08, 2023	BUY	$252.44 - $306.72 $333,473 - $405,177	1,321 Added 52.03%	3,860 $0
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $4,477 - $6,174	23 Added 0.91%	2,539 $678 Million
Q1 2022 May 04, 2022	SELL	$193.77 - $244.14 $702,997 - $885,739	-3,628 Reduced 59.05%	2,516 $530,000
Q4 2021 Feb 02, 2022	BUY	$223.92 - $287.77 $521,733 - $670,504	2,330 Added 61.09%	6,144 $1.47 Million
Q3 2021 Nov 10, 2021	BUY	$282.99 - $369.05 $437,219 - $570,182	1,545 Added 68.09%	3,814 $1.08 Million
Q2 2021 Aug 11, 2021	SELL	$259.0 - $414.71 $56,980 - $91,236	-220 Reduced 8.84%	2,269 $786,000
Q1 2021 May 10, 2021	SELL	$242.95 - $284.63 $409,127 - $479,316	-1,684 Reduced 40.35%	2,489 $696,000
Q4 2020 Feb 11, 2021	BUY	$236.26 - $355.63 $985,912 - $1.48 Million	4,173 New	4,173 $1.02 Million
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $283,232 - $375,092	-1,095 Closed	0 $0
Q1 2020 Apr 30, 2020	SELL	$268.85 - $341.04 $124,746 - $158,242	-464 Reduced 29.76%	1,095 $346,000
Q4 2019 Jan 31, 2020	SELL	$220.06 - $304.07 $70,859 - $97,910	-322 Reduced 17.12%	1,559 $463,000
Q1 2019 May 01, 2019	BUY	$216.71 - $338.96 $94,485 - $147,786	436 Added 30.17%	1,881 $445,000
Q4 2018 Jan 31, 2019	SELL	$278.5 - $352.75 $115,577 - $146,391	-415 Reduced 22.31%	1,445 $435,000
Q3 2018 Nov 07, 2018	BUY	$293.51 - $383.83 $33,460 - $43,756	114 Added 6.53%	1,860 $657,000
Q2 2018 Aug 10, 2018	BUY	$257.52 - $306.91 $14,163 - $16,880	55 Added 3.25%	1,746 $507,000
Q1 2018 May 09, 2018	BUY	$260.13 - $367.91 $66,853 - $94,552	257 Added 17.92%	1,691 $463,000
Q4 2017 Feb 09, 2018	SELL	$307.64 - $344.58 $552,213 - $618,521	-1,795 Reduced 55.59%	1,434 $457,000
Q2 2017 Aug 09, 2017	BUY	N/A	3,229	3,229 $876,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.

Account